Global Healthcare SCM Market 2016-2020

2015-12-09
Price :
Published : Dec-2015
No. of Pages : 63

Market outlook of the healthcare SCM market

The research analyst predicts the global healthcare SCM market to grow steadily at a CAGR of 10% over the next four years. The need to improve traceability in the healthcare SCM system is the primary growth driver for this market. Healthcare SCM helps organizations with labor optimization, financial management, and smooth flow of information throughout the entire supply chain.

Over the years, many SCM software solutions have been developed by the leading players in this market in a bid to reduce errors related to procurement of healthcare devices. Ongoing efforts to implement GS1 standards as a tool to improve healthcare SCM systems will further augment the adoption of SCM in the healthcare sector during the forecast period.

Segmentation and analysis of the healthcare SCM market

  • Supply chain planning
  • Warehouse management system

The supply chain planning segment dominated the market in 2015 with a market share of close to 80%. Supply chain planning solutions provide real-time information about the shipment of the products, which enhances traceability.

Geographical segmentation and analysis of the healthcare SCM market

  • Americas
  • APAC
  • EMEA

The Americas accounted for approximately 55% of the market share in 2015. The growth of the healthcare SCM market in the region can be attributed to the healthcare reforms implemented by different countries such as the Affordable Care Act in the US, which is also known as ObamaCare. The need to enhance supply-chain systems in the Americas is primarily driven by risk management and compliance issues.

Competitive landscape and key vendors

Competition among the vendors in the global healthcare SCM market is fierce because of the presence of numerous player.

The role of IT in healthcare services is becoming important and vendors are consistently investing in developing new products and services for healthcare SCM. Firms are also adopting market consolidation strategies to expand their business globally.

The leading vendors analyzed in this report are -

  • Cardinal Health
  • Cerner
  • Mckesson
  • Oracle

Other prominent vendors in the market include Airclic, Binary Stream, Epicor, Genco, GHX, Infor, JDA Software, Manhattan Associates, Mayo Clinic, Microsoft, Owens & Minor, ROi, Solstice Medical, SAP, TECSYS, and UPS.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global healthcare SCM market?
  • What are the key market trends impacting the growth of the healthcare SCM market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the vendors in the global healthcare SCM market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the healthcare SCM market?
Filed in: Pharmaceutical
Publisher : Technavio
More Reports
Title Price Buy Now

EpiCast Report: Alzheimer’s Disease – Epidemiology Forecast to 2026

EpiCast Report: Alzheimer's Disease - Epidemiology Forecast to 2026 Summary Alzheimer's disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, characterized by the death of brain cells, which leads to a progressive decline in memory and cognitive abilities, such as thinking, language, and learning capacity (NIA, 2017). AD is the most common cause of dementia in people age 60 years and older, and accounts for approximately 75% of the total dementia cases worldwide. To forecast the total prevalent cases of AD in adults ages 60 years and older in the 7MM during the forecast period (2016-2026), our epidemiologists identified country-specific population-based studies that used the diagnostic criteria based on the Diagnostic and Sta......
$3995

EpiCast Report: Epilepsy – Epidemiology Forecast to 2026

EpiCast Report: Epilepsy - Epidemiology Forecast to 2026 Summary Epilepsy is a brain disorder characterized by recurrent and unpredictable seizures that are caused by sudden, disorderly, and excessive neuronal activity in the brain (WHO, 2017). It is one of the most common neurological conditions globally (WHO, 2017). Epilepsy can start at any age and can be a life-long condition. It is diagnosed after a patient has suffered a seizure and is referred to a specialist, where a description of the symptoms before the seizure and the seizure itself are used for a diagnosis (NHS, 2014). In the 7MM, the lifetime diagnosed prevalent cases of epilepsy will increase from almost 11 million cases in 2016 to just over 11.5 million cases in 2026, at an Annual Growth Rate (AGR) of almost 0.5% pe......
$3995

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for August 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in August 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report p......
$1000

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Argentina

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Argentina Summary Pharmaceutical market increased from over US$3 Billion in 2009 to around US$6.5 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of nearly 10%. It is expected to cross US$10 Billion in 2021 at a CAGR of about 10%. In 2009, the medical device market was valued at just over US$1 Billion. It grew at a CAGR of 4% between 2009 and 2016 and reached around US$1.3 Billion. It is expected to grow at a CAGR of about 5%, from around US$1.4 Billion in 2017 to over US$1.7 Billion in 2021. Argentina is the third-largest pharmaceutical market in Latin America after Brazil and Mexico. With a relatively low-cost base and high-quality professionals in the biotechnology sector, Argentina is home to over 130 ......
$1995

EpiCast Report: Melanoma – Epidemiology Forecast to 2026

EpiCast Report: Melanoma - Epidemiology Forecast to 2026 Summary Melanoma is a malignant neoplasm of melanocytes, the pigment cells in the skin located on the epidermis, the most superficial layer of skin (WHO, 2014). Melanocytes are embryological derivatives of neural crest tissue, and as such, any region of the body that is a derivative of the neural crest and contains melanocytes-namely areas of skin, meninges, mucous membranes, esophagus, and eyes-can develop melanoma (Komarnicky-Kocher and Alite, 2013). In the 7MM, our epidemiologists forecast the diagnosed incident cases of melanoma to increase to over 200,000 cases by 2026, at an Annual Growth Rate (AGR) of almost 2.5%. The US will have the highest number of melanoma cases throughout the forecast period. The five-year diagn......
$3995

EpiCast Report: Crohn’s Disease – Epidemiology Forecast to 2026

EpiCast Report: Crohn's Disease - Epidemiology Forecast to 2026 Summary Crohn's disease (CD) is an inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract. While any part of the gastrointestinal tract can be affected, inflammation is most commonly found at the end of the small intestine (ileum), and the start of the large intestine (colon). The disease course of CD is characterized by periods of remission followed by periods of relapse, the length and severity of which differ from case to case (CDC, 2014; NHS, 2015). Inflammation in CD can result in severe scarring and narrowing of the parts of the bowel. Our epidemiologists forecast that the diagnosed incident cases of CD in the 7MM will increase from 70,985 in 2016 to 74,712 in 2026 a......
$3995

Hyperemia Global Clinical Trials Review, H2, 2017

Hyperemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are ......
$2500

Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017

Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hypereosinophilic Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Hypereosinophilic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Hypereosinophilic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary dat......
$2500

Hyperglycemia Global Clinical Trials Review, H2, 2017

Hyperglycemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperglycemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperglycemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Hyperkalemia Global Clinical Trials Review, H2, 2017

Hyperkalemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Hyperkalemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperkalemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperkalemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical......
$2500